{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:45:35Z","timestamp":1787222735091,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/cmr.0b013e328315c690","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T03:23:35Z","timestamp":1225855415000},"page":"412-419","source":"Crossref","is-referenced-by-count":18,"title":["Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma"],"prefix":"10.1097","volume":"18","author":[{"given":"\u00c5sa","family":"Bolander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margr\u00e9t","family":"Agnarsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Wagenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Pont\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brattstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Einarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"Ullenhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Hesselius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bergqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(81)92142-5","article-title":"S100 protein: a marker for human malignant melanomas?","volume":"1","author":"Gaynor","year":"1981","journal-title":"Lancet"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.clinbiochem.2004.05.012","article-title":"S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma","volume":"37","author":"Harpio","year":"2004","journal-title":"Clin Biochem"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0968-0004(96)10020-7","article-title":"The S100 family of EF-hand calcium-binding proteins: functions and pathology","volume":"21","author":"Schafer","year":"1996","journal-title":"Trends Biochem Sci"},{"key":"R4-6-20210129","first-page":"d1356","article-title":"S100 proteins: structure, functions and pathology","volume":"7","author":"Heizmann","year":"2002","journal-title":"Front Biosci"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbamcr.2006.07.013","article-title":"An update of the S100 nomenclature","volume":"1763","author":"Marenholz","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/286400a0","article-title":"S100 protein is present in cultured human malignant melanomas","volume":"286","author":"Gaynor","year":"1980","journal-title":"Nature"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1200\/JCO.2001.19.3.824","article-title":"Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma","volume":"19","author":"Martenson","year":"2001","journal-title":"J Clin Oncol"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0190-9622(99)70254-9","article-title":"S-100 protein in peripheral blood: a marker for melanoma metastases: a prospective 2-center study of 570 patients with melanoma","volume":"41","author":"Kaskel","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R9-6-20210129","first-page":"601","article-title":"S100 protein serum levels in cutaneous malignant melanoma","volume":"5","author":"Seregni","year":"1998","journal-title":"Oncol Rep"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/paor.1999.0218","article-title":"Serum levels of S-100 protein and 5-S-cysteinyldopa as markers of melanoma progression","volume":"5","author":"Banfalvi","year":"1999","journal-title":"Pathol Oncol Res"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/bjc.1998.368","article-title":"The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma","volume":"77","author":"Bonfrer","year":"1998","journal-title":"Br J Cancer"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008390-199912000-00004","article-title":"Evaluation of S-100beta assays for the prediction of recurrence and prognosis in patients with AJCC stage I-III melanoma","volume":"9","author":"Curry","year":"1999","journal-title":"Melanoma Res"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000110424","article-title":"Prognostic implications of protein S-100beta serum levels in the clinical outcome of high-risk melanoma patients","volume":"28","author":"Domingo-Domenech","year":"2007","journal-title":"Tumour Biol"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1200\/JCO.1999.17.6.1891","article-title":"S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma","volume":"17","author":"Deichmann","year":"1999","journal-title":"J Clin Oncol"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000011989","article-title":"S100B protein detection in serum is a significant prognostic factor in metastatic melanoma","volume":"56","author":"Hauschild","year":"1999","journal-title":"Oncology"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02306089","article-title":"Evaluation of new putative tumor markers for melanoma","volume":"3","author":"Miliotes","year":"1996","journal-title":"Ann Surg Oncol"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejca.2004.10.019","article-title":"Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients","volume":"41","author":"Smit","year":"2005","journal-title":"Eur J Cancer"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00008390-199904000-00008","article-title":"Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients","volume":"9","author":"Hauschild","year":"1999","journal-title":"Melanoma Res"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1365-2133.1998.02119.x","article-title":"Clinical and prognostic relevance of serum S-100 beta protein in malignant melanoma","volume":"138","author":"Schultz","year":"1998","journal-title":"Br J Dermatol"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000246103","article-title":"Serum S100 \u2013 a marker for disease monitoring in metastatic melanoma","volume":"194","author":"Henze","year":"1997","journal-title":"Dermatology"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/bjc.1997.232","article-title":"Elevated serum levels of S100 and survival in metastatic malignant melanoma","volume":"75","author":"Buer","year":"1997","journal-title":"Br J Cancer"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med"},{"key":"R23-6-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1385\/CP:1:3-4:285","article-title":"Antibody-based tissue profiling as a tool for clinical proteomics","volume":"1","author":"Kampf","year":"2004","journal-title":"Clin Proteom"},{"key":"R24-6-20210129","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/ijc.1504","article-title":"On the release and half-life of S100B protein in the peripheral blood of melanoma patients","volume":"94","author":"Ghanem","year":"2001","journal-title":"Int J Cancer"},{"key":"R25-6-20210129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2133.1997.18531946.x","article-title":"Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma","volume":"137","author":"Abraha","year":"1997","journal-title":"Br J Dermatol"},{"key":"R26-6-20210129","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9","article-title":"Differential expression patterns of \u2329I\u232aS100a2, S100a4\u2329\/I\u232a and \u2329I\u232aS100a6\u2329\/I\u232a during progression of human malignant melanoma","volume":"74","author":"Maelandsmo","year":"1997","journal-title":"Int J Cancer"},{"key":"R27-6-20210129","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1002\/pmic.200500460","article-title":"Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro","volume":"6","author":"Cui","year":"2006","journal-title":"Proteomics"},{"key":"R29-6-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2133.2000.03650.x","article-title":"Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma","volume":"143","author":"Jury","year":"2000","journal-title":"Br J Dermatol"},{"key":"R30-6-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000095034","article-title":"Detection of melanoma relapse: First comparative analysis on imaging techniques versus S100 protein","volume":"213","author":"Beyeler","year":"2006","journal-title":"Dermatology"},{"key":"R31-6-20210129","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2133.2002.04691.x","article-title":"Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma","volume":"146","author":"Acland","year":"2002","journal-title":"Br J Dermatol"},{"key":"R32-6-20210129","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/modpathol.3800151","article-title":"Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma","volume":"17","author":"Andersen","year":"2004","journal-title":"Mod Pathol"},{"key":"R33-6-20210129","first-page":"633","article-title":"S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD\/SCID\/gammaCnull (NOG) mouse model","volume":"14","author":"Ikoma","year":"2005","journal-title":"Oncol Rep"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CMR.0b013e328315c690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:14:02Z","timestamp":1786036442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008390-200812000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e328315c690","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}